Are you Dr. Gonzalez-Amado?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 20 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
210 E Grand Ave
South San Francisco, CA 94080Phone+1 610-551-2740Fax+1 310-301-8751
Summary
- Dr. Rafael Gonzalez-Amado, MD is a hematologist in South San Francisco, California. He is currently licensed to practice medicine in California.
Education & Training
- UCLA David Geffen School of Medicine/UCLA Medical CenterFellowship, Hematology and Medical Oncology, 1992 - 1995
- University of Illinois College of Medicine at ChicagoResidency, Internal Medicine, 1989 - 1992
- Universidad de Cadiz Faculty of MedicineClass of 1987
Certifications & Licensure
- CA State Medical License 1992 - 2026
Publications & Presentations
PubMed
- 279 citationsAntitumor Activity Associated with Prolonged Persistence of Adoptively Transferred NY-ESO-1c259T Cells in Synovial SarcomaSandra P. D'Angelo, Luca Melchiori, Melinda S. Merchant, Donna Bernstein, John Glod
Cancer Discovery. 2018-06-11 - 88 citationsDose and Schedule Study of Panitumumab Monotherapy in Patients with Advanced Solid MalignanciesLouis M. Weiner, Arie S. Belldegrun, Jeffrey Crawford, Anthony W. Tolcher, Pamela Lockbaum
Clinical Cancer Research. 2008-01-15 - 2353 citationsWild-type KRAS is required for panitumumab efficacy in patients with metastatic colorectal cancerRafael G. Amado, Michael S. Wolf, Marc Peeters, Eric Van Cutsem, Salvatore Siena
Journal of Clinical Oncology. 2008-04-01
Press Mentions
- ZL-1310, an Investigational DLL3-Targeted Antibody-Drug Conjugate (ADC), Demonstrates Promising Objective Response Rates and Safety Profile in Extensive-Stage Small Cell Lung CancerOctober 24th, 2024